Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-22-3p
|
MIMAT0000077 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_42322795 Show fit | 1.16 |
ENST00000291232.3
|
tumor necrosis factor receptor superfamily, member 13C |
|
chr2_+_27371866 Show fit | 0.95 |
ENST00000296096.5
|
transcription factor 23 |
|
chr5_-_41510656 Show fit | 0.92 |
ENST00000377801.3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
|
chr5_+_57878859 Show fit | 0.86 |
ENST00000282878.4
|
RAB3C, member RAS oncogene family |
|
chr1_-_212873267 Show fit | 0.84 |
ENST00000243440.1
|
basic leucine zipper transcription factor, ATF-like 3 |
|
chr1_+_209757051 Show fit | 0.76 |
ENST00000009105.1
ENST00000423146.1 ENST00000361322.2 |
calcium/calmodulin-dependent protein kinase IG |
|
chr7_+_73703728 Show fit | 0.68 |
ENST00000361545.5
ENST00000223398.6 |
CAP-GLY domain containing linker protein 2 |
|
chr6_+_96463840 Show fit | 0.66 |
ENST00000302103.5
|
fucosyltransferase 9 (alpha (1,3) fucosyltransferase) |
|
chr7_+_128577972 Show fit | 0.65 |
ENST00000357234.5
ENST00000477535.1 ENST00000479582.1 ENST00000464557.1 ENST00000402030.2 |
interferon regulatory factor 5 |
|
chr2_-_230933709 Show fit | 0.57 |
ENST00000436869.1
ENST00000295190.4 |
solute carrier family 16, member 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
0.0 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.7 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.6 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.6 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |